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Abstract
Pseudomonas aeruginosa is a metabolically versatile 
environmental bacterium and an opportunistic human 
pathogen that relies on numerous signaling pathways to 
sense, respond, and adapt to fluctuating environmental 
cues. Although the environmental signals sensed by 
these pathways are poorly understood, they are largely 
responsible for determining whether P. aeruginosa adopts 
a planktonic or sessile lifestyle. These environmental 
lifestyle extremes parallel the acute and chronic infection 
phenotypes observed in human disease. In this review, we 
focus on four major pathways (cAMP/Vfr and c-di-GMP 
signaling, quorum sensing, and the Gac/Rsm pathway) 
responsible for sensing and integrating external stimuli 
into coherent regulatory control at the transcriptional, 
translational, and post-translational level. A common theme 
among these pathways is the inverse control of factors 
involved in promoting motility and acute infection and those 
associated with biofilm formation and chronic infection. In 
many instances these regulatory pathways influence one 
another, forming a complex network allowing P. aeruginosa 
to assimilate numerous external signals into an integrated 
regulatory circuit that controls a lifestyle continuum.
Introduction
Pseudomonas aeruginosa is a Gram-negative, metabol-
ically versatile bacterium that exists in a wide range 
of environmental habitats and is a primary agent of 
opportunistic infection in humans, causing both acute and 
chronic infections (Driscoll, 2007). P. aeruginosa thrives in 
many habitats including: aquatic sediments, water exposed 
surfaces, soil, plant roots and leaves, and human and 
animal sewage (Ringen, 1952; Green, 1974; Pellet, 1983). 
Numerous epidemiological studies have compared the 
virulence properties of environmental and clinical isolates of 
P. aeruginosa (Nicas, 1986; Römling, 1994; Ferguson, 2001; 
Wolfgang, 2003a; Pirnay, 2009). With few exceptions it has 
been reported that clinical isolates from acute infections, 
or isolates obtained at the onset of chronic infection, are 
indistinguishable from environmental isolates. These 
studies support the following conclusions: 1) environmental 
strains are the primary source of P. aeruginosa infection, 
and 2) the virulence characteristics of P. aeruginosa are 
pre-existing in the environment. Furthermore, these studies 
indicate that the environmental lifestyle of P. aeruginosa 
involves a repertoire of phenotypes that otherwise support 
and contribute to opportunistic human infections.
 Many P. aeruginosa traits that contribute to human 
virulence can be linked to a particular function relevant to 
its environmental lifestyle. It has been hypothesized that 
the virulence factors used by P. aeruginosa (and other 
opportunistic pathogens) to infect humans evolved as 
defense mechanisms against eukaryotic predators (Hilbi, 
2007). Indeed, it is now well established that P. aeruginosa 
can infect and kill numerous protozoan and non-mammalian 
organisms that likely inhabit the same environmental 
space (Rahme, 1995; Hilbi, 2007). An important defense 
mechanism utilized by P. aeruginosa is the formation 
of surface-attached biofilms, multicellular communities 
encased in a self-produced polysaccharide matrix. Biofilms 
are intrinsically resistant to harsh conditions and provide 
protection from both toxic and antibacterial compounds in 
the environment, as well as predation (Matz, 2005).
 In humans, P. aeruginosa is associated with both acute 
and chronic infections in immunocompromised individuals, 
and is capable of infecting a multitude of sites and tissues, 
including: lungs, burns, wounds, eyes, ears, and indwelling 
medical devices (i.e. catheters and ventilators) (Driscoll, 
2007). Acute P. aeruginosa infections, such as nosocomial 
pneumonia, are invasive and cytotoxic and frequently 
result in substantial tissue damage, systemic spread, 
sepsis, and mortality. The pathogenesis of acute infections 
relies upon the expression of many surface-exposed and 
secreted virulence factors, including: toxins, proteases 
(delivered by a type II secretion system; T2SS), type IV 
pili (Tfp), flagella and a type III secretion system (T3SS) 
that can inject a set of eukaryote specific effectors across 
the plasma membrane of target cells (Sadikot, 2005). The 
virulence factors important for establishing acute infections 
are distinct from those critical for chronic infections. Chronic 
infections are minimally invasive and noncytotoxic. These 
infections involve the formation of biofilms, which in the 
context of human infection, protect against assault by the 
host immune system and provide resistance to antibiotics 
(Donlan, 2002; Ryder, 2007). Thus, chronic infections rarely 
result in systemic spread, but instead lead to unrelenting 
non-productive host inflammation that contributes to the 
resulting morbidity and mortality (Deretic, 1995).
 Chronic pulmonary P. aeruginosa infection in 
individuals with the genetic disease cystic fibrosis (CF) 
serves as a model for environmental acquisition followed 
by genetic adapation to the CF lung and has revealed an 
inverse relationship between expression of acute and 
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chronic virulence determinants. Early in life, CF patients are 
plagued with recurrent transient P. aeruginosa infections 
that mimic bronchitis. By adolescence, transient infections 
are typically replaced by permanent colonization with a 
single strain that persists for the remainder of the individual’s 
life. During the chronic phase of infection, P. aeruginosa 
adopts a biofilm-like lifestyle, persisting within the thickened 
mucus of the airways (Lam, 1980; Singh, 2000). Within 
the CF lung, P. aeruginosa undergoes significant genetic 
adaptation, including the conversion to a mucoid colony 
phenotype, resulting from the overproduction of the 
capsular polysaccharide alginate (Govan, 1996). Additional 
adaptations include mutation and transcriptional repression 
of acute virulence factors within subpopulations (Smith, 
2006; Jones, 2010). The accumulation of these adaptations 
results in the loss of acute virulence in individual isolates, 
and likely results in the gradual loss of acute virulence 
within the population as a whole. Persistent inflammation 
and subsequent lung deterioration in CF patients is the 
primary cause of mortality (Taccetti, 2005).
 The ability of P. aeruginosa to adapt to a diverse set 
of environmental conditions and to cause distinct infections 
relies on its ability to control gene expression in response to 
environmental stimuli. P. aeruginosa devotes a substantial 
proportion of its genomic real estate to regulatory systems that 
sense environmental conditions and integrate information 
to alter gene expression or behavior accordingly (Stover, 
2000). The first P. aeruginosa genome was sequenced in 
2001, revealing a remarkable number of transcriptional 
regulators, and our knowledge of P. aeruginosa regulatory 
pathways has grown exponentially in the subsequent years. 
Recent work in the field has led to the development of the 
hypothesis that the regulatory pathways that control the 
transition from free living (planktonic) to surface-adherent 
community (sessile) livestyles in the environment are likely 
to play a similar role in dictating infection type (acute vs. 
chronic) in human disease. This review will focus on the 
regulatory pathways that have emerged as key determinants 
of P. aeruginosa lifestyle: 1) cAMP/Vfr signaling, 2) c-di-GMP 
signaling, 3) quorum sensing (QS), and 4) the Gac/Rsm 
Figure 1. Model of the regulatory pathways and cross-
talk that modulate P. aeruginosa lifestyles.
Lines depict direct regulatory mechanisms within given 
signaling pathways as well as cross-talk between 
regulatory systems. Arrows represent positive regulation 
and T-bars indicate negative regulation. Blue lines 
represent transcriptional regulation while purple lines 
represent enzymatic reactions. Orange lines depict post-
translational modification events. Black lines illustrate 
post-translational regulation events. Dashed lines indicate 
unknown mechanisms of regulation.  For more details see 
text references to this figure.
A. cAMP/Vfr signaling. The Chp chemosensory system 
modulates the enzymatic activity of CyaB, an adenylate 
cyclase that synthesizes the majority of intracellular cAMP. 
The phosphodiesterase CpdA degrades intracellular cAMP. 
When present in sufficient quantities, cAMP binds to and 
activates the transcription factor Vfr. cAMP/Vfr regulates 
numerous virulence factors, primarily those associated 
with an acute virulence phenotype, in addition to lasR, the 
master regulator of the quorum sensing hierarchy. Both 
vfr and cpdA are transcriptionally regulated by cAMP/Vfr 
creating a feedback loop to maintain cAMP homeostasis.
B. Quorum Sensing. Schematic representation of the 
AHL- and AQ-dependent QS systems in P. aeruginosa. 
LasR activates lasI expression to produce C12-HSL. The 
LasR/C12-HSL complex positively influences expression 
of the second AHL-dependent QS system (RhlRI/C4-HSL) 
and many other target genes. The AHL-dependent systems 
are transcriptionally and post-transcriptionally regulated 
by numerous regulators including two LuxR homologues 
(VqsR and QscR), RsmA, and the alternative sigma factor, 
RpoS. The RhlR/C4-HSL complex negatively regulates the 
AQ-dependent QS system.
C. Gac/Rsm pathway. The GacS/A TCS positively 
regulates expression of two sRNA molecules, RsmY and 
RsmZ, which bind and sequester the RNA-binding protein 
RsmA. Activation of the HptB signaling cascade promotes 
chronic virulence factor expression by specifically activating 
rsmY expression. GacS activity is antagonized by the 
hybrid sensor kinase RetS and promoted by the orphan 
sensor kinase LadS. Free RsmA facilitates the expression 
of acute virulence factors, such as the T3SS, and represses 
expression of chronic virulence factors including the T6SS 
and EPS (Pel and Psl) involved in biofilm formation.
D. c-di-GMP signaling. c-di-GMP levels inversely control 
functions involved in motility (acute) and biofilm formation 
(chronic). Synthesis and degradation of c-di-GMP is 
facilitated by diguanylate cyclases and phosphodiesterases. 
Multiple DGCs and PDEs encoded within the P. aeruginosa 
genome appear to be spatially localized to alter local c-di-
GMP concentrations and influence protein function and 
gene expression by largely unknown mechanisms.
E. MucA signaling. The anti-sigma factor MucA sequesters 
the sigma factor AlgU. During chronic CF infection, mucA 
mutation results in constitutive AlgU activation. AlgU 
increases expression of algR and together AlgU and AlgR 
activate the alginate biosynthetic operon. AlgR negatively 
regulates QS by inhibiting rhlR expression. AlgR inhibits 
vfr expression via an unknown mechanism resulting in 
decreased expression of many acute virulence factors.
F. HptB signaling. Upon activation by an unknown signal 
the sensor kinsase PA2284 transfers a phosphoryl group 
specifically to HptB. HptB then relays the signal to the 
response regulator PA3346. Phosphorylated PA3346 
functions as a Ser/Thr phosphatase and dephosphorylates 
PA3347. Phosphorylation is hypothesized to modulate the 
binding activity of PA3347. In the unphosphorylated state 
PA3347 is thought to bind an anti-sigma factor, resulting in 
the release of an unidentified sigma factor, which specifically 
regulates rsmY expression leading to expression of genes 
associated with swarming motility and biofilm formation.
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pathway. Two of these pathways rely on second messenger 
signaling molecules cAMP and c-di-GMP (adenosine 
3’,5’-cyclic monophosphate and bis-(3′-5′)-cyclic dimeric 
guanosine monophosphate). Cyclic AMP is now recognized 
as a major mediator of acute virulence gene expression and 
planktonic lifestyle phenotypes in P. aeruginosa (Wolfgang, 
2003b). In contrast, c-di-GMP appears to play a critical role 
in controlling chronic infection-related phenotypes and the 
biofilm lifestyle. The coordination of population behaviors is 
also essential in determining the commitment to a particular 
lifestyle. In P. aeruginosa it is evident that QS is an important 
regulator of acute virulence phenotypes (Whiteley, 1999; 
Wagner, 2004; Schuster, 2007); however, it also plays 
a significant role in the transition from the planktonic to 
sessile lifestyle and in the establishment of chronic infection 
(Singh, 2000; Christensen, 2007). Finally, the Gac/Rsm 
pathway appears to act as a global regulator of lifestyle by 
inversely regulating acute virulence factors and planktonic 
behaviors with chronic infection phenotypes and biofilm 
formation. Here we will concentrate on recent advances in 
cyclic nucleotide signaling (cAMP, c-di-GMP), QS, and post-
transcriptional control by the Gac/Rsm pathway. We will 
first summarize each individual pathway and then highlight 
particular regulatory interactions between the pathways. 
Finally, we will discuss the implications of this complex 
regulatory network in controlling P. aeruginosa lifestyle and 
infection outcome.
cAMP/Vfr signaling
The second messenger signaling molecule, cAMP, regulates 
multiple virulence factors involved in P. aeruginosa infection 
(Figure 1A) (Wolfgang, 2003b). Cyclic AMP is involved 
in regulating gene expression in many bacterial species 
in response to environmental cues (De Lorenzo, 1988; 
Botsford, 1992; Macfadyen, 1998) and is produced by the 
enzymatic activity of adenylate cyclase (AC) enzymes. 
The P. aeruginosa PAO1 genome encodes three ACs, the 
intracellular ACs, CyaA and CyaB, and a secreted effector 
ExoY (Stover, 2000; Wolfgang, 2003b). ACs are divided 
into six classes based upon their evolutionary relationships 
(Téllez-Sosa, 2002). ExoY belongs to the class II ACs, 
a group of secreted ACs that function as bacterial toxins 
(Yahr, 1998). ExoY is secreted via the T3SS directly into the 
cytoplasm of target host cells and its activity is dependent 
on a host-encoded cofactor (Yahr, 1998). The role of ExoY 
in virulence is not well understood, although the AC activity 
of ExoY does result in actin disruption and rounding of 
cultured epithelial cells (Cowell, 2005). Mutants lacking 
either CyaA or CyaB have reduced intracellular cAMP; 
however, CyaB appears to synthesize the majority of cAMP 
in P. aeruginosa under laboratory growth conditions and 
during model infection (Wolfgang, 2003b; Smith, 2004). 
In a murine model of acute pneumonia a cyaB mutant is 
attenuated, indicating a role for cAMP in P. aeruginosa 
virulence (Smith, 2004). CyaA is a cytosolic cIass I AC, 
a class found primarily in enterobacteria, while CyaB is a 
member of the class III AC family ubiquitous among both 
eukaryotes and prokaryotes (Baker, 2004). CyaB consists 
of a N-terminal MASE2 (membrane associated sensor 2) 
domain and a C-terminal AC catalytic domain (Nikolskaya, 
2003). The MASE2 domain is thought to function as a 
membrane-anchored sensor that regulates the activity of 
the C-term AC catalytic domain (Nikolskaya, 2003).
cAMP/Vfr regulated virulence associated genes
In enteric bacteria, the effect of cAMP on gene expression 
is mediated through the cAMP-receptor protein (CRP), 
a cAMP-dependent transcriptional regulator. The well-
characterized CRP protein from Escherichia coli, is primarily 
involved in regulating genes associated with carbon 
metabolism in response to glucose availability (Gosset, 
2004). CRP functions as a homodimer and is allosterically 
controlled by binding of cAMP. Following formation of a 
cAMP-CRP complex, CRP undergoes a conformational 
change enabling binding of activated CRP to specific 
DNA sequences within target promoters, facilitating either 
transcriptional activation or inhibition (Botsford, 1992). In P. 
aeruginosa, cAMP influences gene regulation through its 
activity as an allosteric activator of the transcription factor, 
Vfr (virulence factor regulator). Vfr is a member of the 
CRP family of transcriptional regulators, and shares a high 
degree of homology to E. coli CRP (67% sequence identity) 
(West, 1994; Gosset, 2004). Vfr coordinately controls the 
expression of over 200 genes (Suh, 2002; Wolfgang, 2003b) 
and positively regulates the production of virulence factors 
important for acute P. aeruginosa infections, including: Tfp 
(West, 1994; Beatson, 2002; Wolfgang, 2003b), the T3SS 
(Wolfgang, 2003b), the T2SS, secreted toxins, degradative 
enzymes (West, 1994; Beatson, 2002; Wolfgang, 2003b; 
Ferrel, 2008), and the las and rhl QS systems, which control 
hundreds of additional genes, including many virulence 
factors (Albus, 1997; Croda-García, 2011). In contrast, Vfr 
negatively regulates the expression of flagellar genes by 
repressing expression of fleQ, which encodes the master 
regulator of flagellar biogenesis (Dasgupta, 2002).
Allosteric regulation of Vfr: cAMP-dependent/independent 
mechanisms
A consensus Vfr binding sequence has been proposed 
(Kanack, 2006), and direct binding of Vfr to DNA sequences 
within target promoters of several genes including those 
encoding ToxA (toxA), LasR (las quorum-sensing regulator), 
FleQ, RegA and PtxR (toxA expression regulators) and 
CpdA (a cAMP phosphodiesterase) has been demonstrated 
(Albus, 1997; Dasgupta, 2002; Kanack, 2006; Ferrel, 
2008; Fuchs, 2010b). Fuchs et al. further identified both 
cAMP-dependent and -independent Vfr DNA binding 
mechanisms (Fuchs, 2010a). Vfr binding to the majority 
of target promoters specifically requires cAMP. However, 
cAMP is not required for Vfr to bind the lasR promoter in 
vitro or for in vivo lasR promoter activity (Fuchs, 2010a). 
Fuchs and colleagues (2010a) identified a single novel Vfr 
binding site within the vfr promoter, and in vitro transcription 
studies demonstrated that both cAMP and Vfr are required 
for vfr positive autoregulation (Fuchs, 2010a). A similar 
mechanism of autoregulation has been demonstrated for E. 
coli crp (Cossart, 1982; Hanamura, 1992).
 Subtle structural differences exist between the cAMP-
binding pocket of Vfr and E. coli CRP, including the 
presence of three additional amino acids in the Vfr cAMP-
binding pocket (West, 1994; Beatson, 2002). Vfr contains 
a threonine residue (T133) at a position relative to serine 
128 (S128) of E. coli CRP, and threonine substitution of 
CRP S128 results in activation of CRP by both cAMP and 
cGMP (Lee, 1994). Cyclic AMP-dependent gene expression 
in an E. coli crp mutant can be restored by vfr expression. 
However, CRP is not capable of complementing a P. 
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aeruginosa vfr mutant for exotoxin A (ETA) or protease 
production, which suggests that Vfr and CRP cannot be 
functionally interchanged (West, 1994; Suh, 2002). This lack 
of functional complementation may be due to differences 
in cAMP-binding affinity, as Vfr has a higher affinity than 
CRP for cAMP (Serate, 2011). Alternatively, the helix-turn-
helix (H-T-H) DNA binding motifs of Vfr and CRP are not 
identical and may reflect subtle differences in DNA binding 
site recognition (Kanack, 2006).
 In P. aeruginosa, several studies have reported 
conflicting results regarding the ability of Vfr to bind cGMP 
(Beatson, 2002; Fuchs, 2010a; Serate, 2011). A spontaneous 
Vfr mutant (VfrΔEQERS) that lacks 5 amino acids (EQERS) in 
the cyclic nucleotide-binding domain, including two residues 
critical for cAMP binding, was incapable of activating Tfp-
dependent twitching motility, a form of surface-movement 
(Mattick, 2002), but retained the ability to regulate a subset of 
virulence phenotypes (elastase and pyocyanin production) 
(Beatson, 2002). Homology modeling of VfrΔEQERS on a 
CRP-cAMP backbone suggests that VfrΔEQERS may have a 
weaker affinity for cNMP molecules than E. coli CRP or wild 
type Vfr. Beatson et al., suggest that the VfrΔEQERS mutant 
is incapable of regulating twitching motility but retains the 
ability to regulate other virulence factors due to altered 
cyclic nucleotide recognition (Beatson, 2002). Specifically, 
the authors suggest that another cyclic nucleotide (cGMP) 
may be responsible for regulating twitching motility, and the 
VfrΔEQERS mutant may no longer effectively bind this cyclic 
nucleotide, while regulation of elastase and pyocyanin 
production is maintained though cAMP autoregulation of 
Vfr. However, elastase production is also regulated by the 
las QS system (Gambello, 1991). Given that Vfr controls 
lasR expression in a cAMP-independent manner (Fuchs, 
2010a), it is likely that VfrΔEQERS no longer responds to 
cyclic nucleotides, but can still activate cAMP-independent 
promoters. Fuchs et al. (2010a) demonstrated that apo-
Vfr was unable to bind promoter DNA in the presence of 
cGMP and high cGMP concentrations actually inhibited 
Vfr-DNA complex formation (Fuchs, 2010a). In contrast, 
Serate and colleagues (2011) reported that cGMP was 
capable of facilitating Vfr-DNA complexes in vitro; although, 
a significantly higher concentration of cGMP was required 
compared to cAMP for DNA binding (Serate, 2011). The 
conflicting results from the Fuchs and Serate studies were 
obtained utilizing very different experimental assays, which 
may account for their discrepancies (Fuchs, 2010a; Serate, 
2011). Although the effect of cGMP on Vfr activity has not 
been definitively determined, it is important to note that both 
of these studies utilized cGMP concentrations that are not 
likely to be achieved in vivo, and thus cGMP is unlikely to be 
a biologically relevant Vfr ligand. 
CbpA: A cAMP-binding protein
Genome analysis studies have identified additional cyclic 
nucleotide-binding proteins in many bacterial species, 
suggesting that cAMP-binding proteins are involved in 
regulating a variety of processes in prokaryotes (Botsford, 
1992). Bioinformatic analysis identified a novel cAMP-
binding protein in P. aeruginosa PAO1, termed CbpA 
(cAMP-binding protein A). Using structural modeling and 
functional studies, Endoh and Engel determined that CbpA 
is comprised of a C-terminal CAP domain, which binds 
cAMP, and a N-terminal degenerate CAP domain (Endoh, 
2009). A putative Vfr-binding site (VBS) was identified 
upstream of the cbpA translational start site. Mutation of 
the putative cbpA-associated VBS resulted in decreased 
cbpA transcription compared to wild type, indicating that 
Vfr likely regulates cbpA expression. Subsequent EMSA 
studies confirmed binding to a DNA fragment containing 
the VBS identified in the cbpA promoter (Endoh, 2009). As 
Vfr regulates cbpA transcription, the effect of cbpA mutation 
on Vfr-regulated phenotypes (protease secretion, T3S, 
twitching motility, and biofilm formation) was investigated. 
In all cases, cbpA mutation had no effect on Vfr-dependent 
phenotypes, and a cbpA mutant was not attenuated in a 
mouse model of pneumonia. 2D-PAGE determined that 
CbpA does not affect expression or degradation of proteins, 
as no significant difference in protein expression profiles 
between wild type and a cbpA mutant was observed. Taken 
together these results suggest that CbpA does not influence 
the function of any known Vfr-regulated gene products and 
has an unknown function in P. aeruginosa (Endoh, 2009). 
Interestingly, CbpA-GFP fusion proteins were used to 
determine that CbpA levels are growth-phase regulated and 
CbpA localizes to the flagellated old cell pole in a cAMP-
dependent manner (Endoh, 2009), which may provide 
insight into the function of this protein.
cAMP homeostasis
As cAMP is a membrane-impermeable molecule, in order 
to maintain homeostasis and reset the cAMP-signaling 
cascade subsequent to activation, the intracellular cAMP 
concentration must be tightly controlled. Homeostasis can 
be achieved through a number of regulatory mechanisms, 
including control at the level of cAMP synthesis, degradation, 
and excretion. Signal attenuation can be achieved via 
degradation of cAMP to 5’-AMP by the enzymatic activity of 
cyclic 3’-5’-AMP phosphodiesterases. In P. aeruginosa the 
cAMP phosphodiesterase, CpdA, has been characterized. 
CpdA was shown to have cAMP phosphodiesterase activity 
in vitro and plays a pivotal role in cAMP homeostasis in 
vivo (Fuchs, 2010b). Furthermore, the cAMP-Vfr complex 
positively regulates cpdA expression. CpdA protein 
reduces intracellular cAMP levels creating a feedback loop 
(Fuchs, 2010b). Cyclic AMP homeostasis allows specific 
cAMP concentrations to be achieved, which may result 
in a hierarchy of gene expression within the cAMP-Vfr 
regulon. Upregulation of cpdA by cAMP-Vfr at high cAMP 
levels would promote cAMP degradation and likely limits 
the expression of cAMP-Vfr-dependent genes to a narrow 
temporal window.
 In P. aeruginosa cAMP homeostasis is also regulated 
at the level of AC activity. In a screen to identify regulators 
of CyaB function, numerous components of the Chp 
chemotaxis-like chemosensory system were identified 
(Fulcher, 2010). The Chp system components are 
homologous to the E. coli chemotaxis system responsible 
for controlling flagellar motility (Silversmith, 1999). The Chp 
system was previously shown to control Tfp production 
and twitching motility (Darzins, 1997; Whitchurch, 2004). 
Additionally, the Chp system appears critical for P. aeruginosa 
virulence, as mutants are attenuated in a Drosophila model 
of P. aeruginosa infection. The reduced virulence displayed 
by these mutants was more significant than could be 
attributed to their role in Tfp regulation alone (D'Argenio, 
2001). A subset of mutants (pilG (cheY), pilI (cheW), pilJ 
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(MCP), chpA (cheA), fimL, fimV) displayed reduced cAMP 
levels. Increased cAMP levels were measured in the pilK 
(cheR) and pilH (cheY) mutants compared to the parental 
strain (Fulcher, 2010). These results indicate that Chp gene 
cluster (pilGHIJKchpABC) along with fimL and fimV affect 
cAMP intracellular concentrations and exert either a positive 
(pilG, pili, pilJ, chpA, chpC, fimL, fimV) or negative (pilH, 
pilK, and chpB) regulatory effect. fimL mutants resemble 
cyaB mutants for a variety of phenotypes including twitching 
motility defects, decreased T3SS transcription, as well as 
decreased cAMP levels (Inclan, 2011). Additionally, it was 
shown that FimL, CyaB and PilJ (Delange, 2007; Inclan, 
2011) are polarly localized; which suggests that FimL 
functions to link the Chp system and CyaB to regulate the 
spatial and temporal production of cAMP to specifically 
influence polarly localized structures (Tfp and T3SS) 
(Delange, 2007; Inclan, 2011). Western blot analysis 
determined that CyaB expression was equivalent among all 
the Chp mutants compared with the parental strain (Fulcher, 
2010) and thus Chp does not appear to modulate CyaB 
expression. To address the possibility that Chp mutants 
control cAMP levels by controlling cAMP degradation, the 
effect of PilG and PilH (both CheY homologs) on intracellular 
cAMP levels was assessed. Using a genetic approach it 
was demonstrated that PilG and PilH do not regulate cAMP 
levels via degradation, but specifically affect CyaB activity 
(Fulcher, 2010). These results support a model whereby the 
Figure 2. Pseudomonas aeruginosa exhibits parallel 
lifestyle extremes in the environment and human host.
The interplay of four global regulatory pathways (cAMP, c-di-
GMP, Quorum sensing and Gac/Rsm) appears to create a 
phenotypic continuum that controls transition between a 
planktonic and sessile lifestyle within the environment; and 
plays an analogous role in human infection by inversely 
controlling acute and chronic infection phenotypes.
1. In the environment P. aeruginosa can exist as planktonic 
cells or small groups of free living motile organisms, 
providing the means to colonize new environmental 
niches. 2. As the population increases, cells associate 
as a quorum, producing QS signal molecules and exhibit 
social behaviors (degradative enzyme and toxin secretion), 
which promote nutrient acquisition and group survival 
among environmental predators. 3. Upon interaction 
with a solid surface, P. aeruginosa can attach via Tfp or 
flagella. 4. Following loose-attachment, P. aeruginosa 
may exhibit surface motility utilizing Tfp or flagella to 
move toward nutrients. Upon generation of an intimate 
surface attachment, P. aeruginosa may initiate microcolony 
formation. 5. Eventually P. aeruginosa becomes sessile 
and produces exopolysaccharides that encase the bacteria 
in a complex matrix, which protects the bacteria from 
environmental fluctuations and provides a physical barrier 
against predators. 6. Unknown environmental signal(s), 
or stochastic processes, cause members of the sessile 
community to become motile, leave the biofilm, and return 
to a planktonic lifestyle.
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Chp system controls intracellular cAMP pools by affecting 
CyaB activity, although it remains to be determined whether 
this effect is direct or occurs through additional proteins.
Environmental signals affecting intracellular cAMP
The signal(s) resulting in activation of the Chp system 
are not known. However, in vitro culture conditions of low 
calcium (Wolfgang, 2003b) or high osmolarity (Rietsch, 
2006) influence intracellular cAMP levels, but whether 
these represent relevant signals in vivo remains to 
be determined. As the Chp system also regulates Tfp 
production and twitching motility, the chemoattractants 
(phophatidylethanolamine and/or phosphatidylcholine) 
known to affect twitching motility in P. aeruginosa may 
serve as signals that influence cAMP levels (Kearns, 2001; 
Barker, 2004).
Quorum Sensing
Quorum sensing (QS) is a form of bacterial cell-cell 
communication utilized by many species to sense population 
density and coordinate gene expression. QS is achieved 
by self-production of small diffusible signaling molecules 
termed autoinducers, such that increases in the bacterial 
population density results in accumulation of signaling 
molecules. Once a threshold concentration is achieved, the 
autoinducers bind their cognate receptors, which directly 
or indirectly activate gene expression. P. aeruginosa 
encodes three QS systems, two N-acyl-homoserine lactone 
(AHL) based signaling systems (las and rhl) and a 2-alkyl-
4-quinolone (AQ) based signaling system (Figure 1B). 
These three QS systems are involved in the regulation of 
virulence factor production, biofilm maturation, and motility 
phenotypes. The P. aeruginosa QS systems are arranged 
hierarchically with the las system positively regulating both 
the rhl (Latifi, 1996; Pesci, 1997) and AQ (Wade, 2005) 
systems. Additionally, the rhl system negatively regulates 
the AQ system (McGarth, 2004), and each of these systems 
are further modulated by a plethora of regulators that 
function at both the transcriptional and post-transcriptional 
level.
AHL-dependent QS systems
Each of the P. aeruginosa QS systems utilizes a structurally 
distinct diffusible autoinducer and cognate regulator protein 
pair to control downstream gene expression. The las and 
rhl systems use dedicated autoinducer synthases (LasI 
and RhlI) to produce the acyl-homoserine lactone (acyl-
HSL) molecules N-(3-oxododecanoyl)-HSL (C12-HSL) 
and N-butyryl-HSL (C4-HSL), respectively. When sufficient 
autoinducer concentrations are achieved, the molecules 
bind and activate their cognate receptors, LasR and RhlR 
(Juhas, 2005; Schuster, 2006). Together the las and rhl 
systems directly or indirectly regulate roughly 10% of the 
P. aeruginosa genome (Schuster, 2006). Transcriptome 
analysis has revealed significant overlap between the 
regulons of these two systems (Schuster, 2003). The 
most abundant class of QS-regulated genes identified by 
microarray studies were those that encode secreted factors 
(toxins and extracellular enzymes).
 Activation of target genes has been shown to require 
C12-HSL-dependent multimerization of LasR (Kiratisin, 
2002). In contrast, RhlR requires C4-HSL for activation, 
but is not dependent on C4-HSL binding for dimerization 
(Ventre, 2003). Both the las and rhl systems contain a 
positive feedback loop where their regulators, LasR and 
RhlR, induce transcription of their cognate synthase genes 
allowing for rapid signal amplification (Seed, 1995; Latifi, 
1996). Further, binding of the LasR-C12-HSL complex 
activates transcription of rhlR and rhlI, accounting for the 
hierarchical relationship between the two systems (Latifi, 
1996; Pesci, 1997).
 Biochemical analyses have revealed distinct differences 
in the DNA-binding properties of LasR and RhlR. Schuster 
et al. (2004) demonstrated that LasR recognition sequences 
do not require dyad symmetry, and that the presence or 
absence of dyad symmetry corresponds with cooperative 
or non-cooperative binding of LasR to promoter sequences 
(Schuster, 2004b). In contrast, rhl-responsive promoters 
appear to rely on dyad symmetry, highlighting probable 
determinants that facilitate promoter specificity. Indeed the 
recognition sequences for LasR and RhlR do not appear 
to be constrained to a single consensus sequence, rather 
the quorum-controlled promoters have a high degree of 
heterogeneity, thus generating a signaling continuum; 
where some promoters respond to C12-HSL signal alone, 
both C12- and C4-HSL signals, or C4-HSL signal alone 
(Schuster, 2007).
AQ-dependent QS system
The third P. aeruginosa QS system utilizes an AQ signaling 
molecule, designated the Pseudomonas Quinolone Signal 
(PQS; 2-heptyl-3-hydroxy-4-quinolone). PQS is synthesized 
by gene products encoded by the pqsABCD operon and 
pqsH, which are also involved in the production of other 
AQs including the immediate PQS precursor, 2-heptyl-4-
quinolone (HHQ) (Deziel, 2005; Wade, 2005). PQS binds 
with high affinity to its cognate LysR-type receptor MvfR 
(PqsR); together PQS and MvfR control approximately 140 
genes, most of which are co-regulated by the rhl system 
(Deziel, 2005). Interestingly, PQS activates rhlI expression 
(McKnight, 2000) while the rhl system negatively regulates 
the AQ-dependent QS system (McGarth, 2004). Moreover, 
MvfR is positively controlled by LasR-C12-HSL, indicating 
that a delicate balance in the ratio of C12-HSL to C4-HSL is 
necessary for production of PQS (McGarth, 2004).
 AQ-dependent signaling is a critical component of the 
P. aeruginosa QS circuit. The exogenous addition of PQS to 
bacterial cultures promotes biofilm formation and positively 
influences the production of QS-regulated virulence 
factors, particularly pyocyanin and proteases (McKnight, 
2000; Diggle, 2003). PQS appears to act as an allosteric 
regulator of MvfR as binding of MvfR to the pqsABCD 
promoter is greatly enhanced by the PQS (Wade, 2005; 
Xiao, 2006). The pqsABCD gene products direct synthesis 
of the precursor molecule HHQ, which is also capable of 
potentiating MvfR binding to the pqsABCD promoter (Xiao, 
2006). Furthermore, a pqsH mutant incapable of converting 
HHQ to PQS, does not display a defect in MvfR-mediated 
gene expression or virulence, indicating that HHQ is also a 
functional QS molecule (Xiao, 2006).
Regulators of QS homeostasis
In P. aeruginosa, expression of QS controlled genes is 
largely delayed until the stationary phase of growth. While 
this observation suggests that the threshold concentration 
of autoinducers is not achieved until stationary phase, 
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exogenous addition of AHLs or PQS to P. aeruginosa 
strains during logarithmic growth does not result in the 
immediate activation of QS-dependent gene expression 
(Whiteley, 1999; Diggle, 2002; Schuster, 2003). In contrast, 
overexpression of the QS receptor proteins LasR and RhlR 
during logarithmic growth, in the presence of their cognate 
autoinducers, results in the advanced expression of many, 
but not all, QS-controlled genes (Schuster, 2007). Taken 
together, these observations suggest that activation of QS 
genes requires additional factors that likely control receptor 
expression or function, and/or act as coregulators of some 
QS-controlled target genes.
 The transcriptional regulator RsaL, encoded by the 
rsaL gene, represses lasI expression through direct binding 
to the lasI promoter (de Kievet, 1999; Rampioni, 2006). 
Expression of rsaL is positively regulated by LasR-C12-
HSL (de Kievet, 1999), creating a negative feedback loop 
within the las system. Negative regulation of lasI by RsaL 
serves to counterbalance the positive feedback loop in 
which LasR-C12-HSL binds the lasI promoter, enhancing 
lasI expression and C12-HSL production. The rsaL and 
lasI genes are divergently transcribed and coregulated. 
LasR binding to the lasI-rsaL intergenic region triggers 
transcription of both genes (Whiteley, 2001; Schuster, 
2004b), while RsaL binding results in repression of lasI-rsaL 
transcription (Rampioni, 2007), ensuring tight control of this 
negative regulator. Rampioni et al. (2007) demonstrated that 
while RsaL and LasR are capable of binding simultaneously 
to the intergenic region; repression by RsaL supersedes 
LasR-mediated activation (Rampioni, 2007). RsaL appears 
to be a global regulator, controlling ~130 genes independent 
of its effect on lasI expression (Rampioni, 2007), including 
genes whose products are involved in antibiotic resistance 
and biofilm formation in P. aeruginosa (Rampioni, 2009). 
Evidence for rsaL upregulation was found in P. aeruginosa 
RNA harvested from sputum samples obtained from 
chronically infected CF patients, suggesting that RsaL 
plays a role in C12-HSL homeostatic control during chronic 
infection (Son, 2007).
 Given that most QS-controlled genes are expressed 
during stationary phase, it is not surprising that the 
stationary phase sigma factor, RpoS (σS), has been 
shown to modulate the expression of approximately 40% 
of QS-controlled genes (Whiteley, 2000; Schuster, 2004a). 
Expression of rpoS is modestly activated by the rhl QS 
system (Latifi, 1996; Wagner, 2003); however, the presence 
of RpoS promoter sequences in several QS-controlled 
genes suggests that RpoS regulates QS gene expression 
directly (Schuster, 2004a). Furthermore, RpoS appears to 
have an indirect effect on QS gene expression as it plays 
a subtle role in activating lasR and rhlR expression during 
stationary phase (Schuster, 2004a). While the details of the 
interplay between QS and RpoS are poorly understood, it 
is clear that RpoS is involved in restricting QS control of a 
subset of genes until the onset of stationary phase.
 In addition to RpoS, other global regulators elicit 
significant control over QS. Mutation of the mvaT gene 
results in premature and elevated expression of quorum-
regulated genes, demonstrating that MvaT is involved 
in controlling the magnitude and timing of QS-dependent 
gene expression (Diggle, 2002). MvaT is a member of 
the histone-like nucleoid structuring (H-NS) protein family, 
involved in transcriptional silencing (Vallet, 2004). MvaT and 
its homolog MvaU bind specific sequences in AT-rich DNA 
and oligomerize to form extended protein-DNA complexes 
that prevent transcription (Castang, 2008). MvaT/U control 
the expression of approximately 150 genes. Transcriptional 
profiling and genome wide location analysis (chromatin 
immunoprecipitation combined with tiled whole genome 
microarray mapping) revealed that MvaT/U are likely to be 
involved in silencing as many as 350 genes. Among these, 
MvaT/U appear to play a direct role in regulating lasR, 
lasI, rsaL, mvfR, and rpoS, providing a link to all three P. 
aeruginosa QS systems (Castang, 2008).
 While QS homeostasis is subject to control by the 
above global regulators, other regulators have been 
identified that appear to specifically modify QS. VqsR 
(virulence and quorum-sensing regulator), a member of 
the LuxR-type family of transcriptional regulators, appears 
to provide another feedback mechanism to finely tune the 
QS system. Specifically, VqsR has been shown to control 
production of AHL signaling molecules and virulence factors. 
Transcriptome analysis of a vqsR mutant demonstrated that 
VqsR regulates the expression of a subset of QS controlled 
genes, although VqsR has not been shown to bind AHLs 
(Juhas, 2004). Further, LasR binds the vqsR promoter in 
vitro in the presence of C12-HSL (Li, 2007), indicating that 
vqsR expression in under the control of the las QS system.
 The AraC-type transcriptional regulator VqsM positively 
regulates the QS systems. Global transcriptome analysis 
revealed approximately 300 genes that were directly or 
indirectly influenced by vqsM mutation. Of these, 200 genes 
were upregulated by VqsM. More than half of the genes 
positively controlled by VqsM are also activated by QS. 
This is likely due to VqsM control of several important QS 
regulators including (mvfR, rhlR, rsaL, rpoS, and vqsR). 
Overexpression of vqsR in the vqsM mutant restored the 
expression of AHL signaling molecules and most virulence 
factors, indicating that VqsM regulates QS signaling 
primarily through modulation of vqsR expression (Dong, 
2005).
Control of the QS threshold
C12-HSL reaches steady state levels long before P. 
aeruginosa reaches stationary phase and activation of the 
QS system occurs (Chugani, 2001), indicating that additional 
homeostatic mechanisms must control the timing of QS 
activation. Recently several factors involved in regulating 
the activation threshold of quorum-regulated genes have 
been identified. QscR, another LuxR homolog modulates 
the timing of QS activation by repressing expression of lasI 
(Chugani, 2001). QscR exists as an oligomer or aggregate 
in cells, but crosslinking experiments demonstrated that 
QscR is also capable of forming heterodimers with LasR 
or RhlR. Interaction of QscR with AHL signal molecules 
resulted in disassociation of the QscR oligomer (Ledgham, 
2003). Transcriptome studies demonstrated that QscR 
controls a discrete regulon independent of RhlR and 
LasR and can function as either an activator or repressor 
(Lequette, 2006). Expression of qscR is not affected by lasR 
mutation, despite the presence of a well conserved “lux box” 
upstream of qscR (Ledgham, 2003).
 Siehnel and colleagues identified a unique regulator 
(QteE) involved in inhibiting pre-quorum threshold 
transcription. QteE blocks the expression of QS-regulated 
genes without affecting transcription or translation of 
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lasR, indicating a post-translational control mechanism. 
Expression of qteE prevented LasR accumulation 
presumably by affecting protein stability. QteE also reduced 
RhlR accumulation and blocked Rhl-mediated signaling. 
Overexpression of lasR overcame the effects of qteE 
expression, suggesting that the stoichiometry between 
LasR and QteE is important for QteE control (Siehnel, 
2010). Given these results, a model emerges whereby QteE 
activity exceeds LasR activity at low cell densities, but LasR 
activity is favored as the cell density increases. However, 
it has yet to be determined whether QteE affects LasR 
stability in the presence or absence of bound signal.
 QslA was identified in a screen for proteins that 
interact with LasR (Seet, 2011). QslA homologs are 
found within several other Pseudomonas species, and 
share approximately 30% sequence identity at the amino 
acid level; however, none of these homologs have been 
characterized. The predicted secondary structure of QslA 
shares a conserved alpha helical structure with TraM and 
TraM2, anti-activators that inhibit QS activation via protein-
protein interactions in Agrobacterium tumefaciens (Chen, 
2004a). Co-immunoprecipitation assays demonstrated that 
QslA modulates LasR activity via protein-protein interaction. 
Further, QslA disrupted binding of LasR to the lasI-rsaL 
intergenic region in EMSA studies, even when a LasR-
DNA complex was formed prior to the addition of purified 
QslA (Chen, 2004a; Seet, 2011). Chromatography analysis 
determined that QslA (11.8 kDa) exists in solution as a 66 
kDa hexamer. Based on previous reports that LasR exists 
as a dimer (Schuster, 2004b), Seet et al. postulate that 
three pairs of LasR dimers interacts with a QslA hexamer. 
As both QscR and QslA affect LasR dimerization and DNA-
binding respectively, each of these proteins is critical for 
establishing the QS threshold by modulating free LasR 
levels. Importantly, at high concentration C12-HSL disrupts 
QscR inhibition of LasR (and RhlR), while QslA inhibition 
is not affected by increasing C12-HSL concentrations, 
suggesting that QslA may control the overall QS threshold. 
Transcriptome and proteome profiles of P. aeruginosa 
propagated under a variety of experimental conditions 
demonstrate that QS often controls specific sets of genes 
in response to particular environmental cues. These 
results suggest that the QS circuitry may be critical to 
regulating genes in response to both population density and 
environmental stimuli.
Gac/Rsm Pathway
The Gac/Rsm pathway appears to play a fundamental role in 
controlling the course of P. aeruginosa infection by inversely 
regulating the expression of virulence factors associated 
with acute (T3S, Tfp) and chronic (exopolysaccharides, 
type VI secretion (T6S)) disease (Figure 1C) (Goodman, 
2004; Heurlier, 2004; Burrowes, 2006; Ventre, 2006; 
Brencic, 2009a; Moscoso, 2011). In contrast to cAMP/
Vfr signaling and the QS systems, the Gac/Rsm pathway 
controls virulence factor expression post-transcriptionally, 
via alteration of mRNA stability or translation (Smith, 2004). 
Central to this phenotypic switching mechanism is the 
GacS/A two component system (TCS). When activated 
via phosphorylation, GacA promotes the expression of two 
small untranslated RNAs (sRNAs), RsmY and RsmZ, which 
sequester the mRNA-binding protein RsmA (Heurlier, 2004; 
Kay, 2006; Brencic, 2009a). RsmY and RsmZ are comprised 
of multiple stem-loop structures containing GGA motifs in 
unpaired regions that facilitate high affinity binding of RsmA 
(Valverde, 2003). As such, RsmZ and RsmY expression 
levels are inversely proportionate to cellular levels of free 
RsmA. Deletion of rsmY and rsmZ results in phenotypes 
similar to those of a gacA mutant, suggesting that the GacS/A 
system primarily functions to modulate expression of these 
sRNA genes (Kay, 2006; Brencic, 2009a). Activated GacA 
binds a conserved sequence element termed the GacA 
box (TGTAAGN6 CTTACA, N= any nucleotide) present in 
the rsmY and rsmZ promoters (Brencic, 2009b). RsmY 
and RsmZ are also part of a feedback mechanism and 
inhibit their own transcription by interfering with the GacS/A 
system, though it is unclear whether this is accomplished 
by inhibiting GacA phosphorylation, by preventing GacA 
binding to the GacA box, or by inhibiting GacS/A translation. 
While the mechanism of this feedback regulation remains to 
be determined, it is apparent that RsmY and RsmZ levels 
are subject to tight homeostatic control.
RsmA: a post-transcriptional regulator
RsmA is a member of the CsrA family of small translational 
regulatory proteins that have been identified in numerous 
bacteria and are known to regulate multiple aspects of 
virulence gene expression (Lapouge, 2008). Transcriptome 
analyses have defined the RsmA regulon, demonstrating 
negative control of T6S and exopolysaccharide (EPS) 
production involved in biofilm formation as well as positive 
control of T3S, Tfp synthesis, and flagellar motility 
(Burrowes, 2006; Brencic, 2009a). The mechanism of RsmA 
mediated translational repression has been extensively 
characterized. RsmA and RsmA-like proteins of the CsrA 
family bind GGA motif(s) present within the untranslated 5’ 
sequence of target mRNAs, thus occluding the ribosome 
binding site and preventing ribosome recruitment (Lapouge, 
2008). In contrast, the mechanism by which RsmA positively 
regulates expression of T3S, Tfp, and flagellar genes 
remains largely unknown. The E. coli RsmA homolog, CsrA, 
positively affects translation by promoting mRNA stability 
(Wei, 2001), which may represent a standard mode of 
positive regulation for this protein family. Alternatively, it has 
been proposed that positive regulation by RsmA may be 
indirectly attributed to negative regulation of one or more 
transcriptional repressors by RsmA (Brencic, 2009a).
Additional regulators of the GacS/A system
Several additional accessory regulators modulate the 
GacS/A system. Two hybrid sensors lacking cognate 
sensor kinases, RetS and LadS, have antagonistic roles 
relative to one another, and exert negative and positive 
effects respectively on rsmZ expression (Goodman, 
2004; Laskowski, 2006; Ventre, 2006). retS (regulator of 
exopolysaccharides and T3S) and rsmA mutants have 
similar phenotypes including hyperbiofilm formation, 
reduced T3S expression and cytotoxicity, and diminished 
twitching motility (decreased Tfp expression) (Pessi, 2001; 
Goodman, 2004; Zolfaghar, 2005; Goodman, 2009). LadS 
(lost adherence sensor) was identified in a transposon 
library screen for mutants reduced in the ability to form 
biofilms (Vallet, 2001).
 Both RetS and LadS are modular proteins containing 
N-terminal 7TMR-DISMED2 (7-transmembrane-receptor 
with diverse intracellular signaling modules extracellular 
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domain 2) and a 7TMR-DISM_7TM (seven transmembrane 
segments found adjacent to 7TMR-DISM domains) and 
C-terminal response regulator-like receiver domains, 
although RetS contains two receiver domains (Goodman, 
2004; Ventre, 2006). The N-terminal domains of these 
proteins have been predicted to bind carbohydrates and 
their modest (35%) sequence identity suggests they 
may bind similar, but distinct ligands. RetS and LadS 
functionally interact with the GacS/A system. Interestingly, 
RetS activity is independent of conserved phosphorelay 
residues in RetS and the observation that RetS lacks 
autophosphorylation activity suggests that RetS exerts its 
regulatory function directly (Hsu, 2008; Goodman, 2009). 
RetS has recently been shown to heterodimerize with GacS 
resulting in suppression of GacS autophosphorylation 
and thus inhibits phosphotransfer to GacA (Goodman, 
2009). This mechanism of sensor kinase inhibition via 
heterodimerization is novel among signaling proteins. 
The mechanism for GacA activation, via LadS, has not 
been fully characterized but recent work in P. fluorescens 
suggests that it also likely makes physical contact with 
GacS (Workentine, 2009). While transcriptome analysis 
of the RetS regulon revealed 397 target genes, LadS only 
affects the expression of 79, with slightly over half of these 
overlapping with those inversely affected by RetS (Ventre, 
2006). These results indicate that RetS and LadS function to 
reciprocally regulate numerous gene targets via functionally 
altering GacS/A output.
The HptB signaling module
The P. aeruginosa genome is predicted to encode 12 hybrid-
type kinases and 3 putative single domain Hpt proteins in 
addition to numerous TCS proteins (Stover, 2000; Chen, 
2004b). One of these these hybrid sensors, PA2284, was 
identified in a transposon mutant screen for its association 
with the hyberbiofilm phenotype (Goodman, 2004). This 
hybrid sensor, along with two additional hybrid sensors, was 
demonstrated to transfer a phosphoryl group to the histidine 
phosphotransfer protein (HptB) (Hsu, 2008). HptB then 
relays the signal (phosphoryl group) to the orphan response 
regulator PA3346 as demonstrated via in vitro and in vivo 
experiments (Figure 1F) (Lin, 2006; Hsu, 2008).
 Phosphorelay profiling assays determined that HptB 
does not interact directly with GacA; instead HptB interacts 
directly with the response regulator PA3346. PA3346 
is a phosphatase consisting of a N-terminal phosphoryl 
signal receiver domain and a C-terminal eukaryotic type 
Ser/Thr phosphatase domain (Hsu, 2008). Bioinformatic 
analysis of the P. aeruginosa PAO1 genome revealed 
that hptB (PA3345), PA3346, and PA3347 are clustered 
closely together and reverse transcription PCR confirmed 
the operonic structure (Hsu, 2008). Hsu et al. further 
demonstrated via two-hybrid experiments that the output 
domain of PA3346 interacts directly with PA3347, a 
protein with similarity to an anti-sigma (σ) factor. These 
observations suggest that PA3346 regulates PA3347 via 
dephosphorylation, and is supported by the finding that the 
conserved serine-56 residue of PA3347 is phosphorylated 
in vivo and the degree of PA3347 phosphorylation inversely 
correlated with the amount of PA3346 (Hsu, 2008). The 
activity of PA3346/PA3347 was also shown to specifically 
impact rsmY expression without affecting rsmZ. These 
results led to the hypothesis that an unidentified σ factor is 
released upon activation of the HptB pathway, and the freed 
σ factor binds the rsmY promoter but not the rsmZ promoter 
(Figure 1F).
 The HptB signaling pathway is involved in the 
regulation of swarming motility, a form of surface-associated 
motility, and biofilm formation. A hptB mutant is defective 
for swarming motility while mutants lacking PA3346 and 
PA3347 display enhanced swarming motility (Hsu, 2008). 
Biofilm synthesis and disintegration was faster in a hptB 
mutant compared to wild type, while a mutant lacking 
PA3347 was indistinguishable from the parent PAO1 strain 
(Hsu, 2008; Bordi, 2010). Introduction of the PA3346 
or PA3347 mutations into a hptB mutant background 
ablated the hyperbiofilm phenotype (Bordi, 2010). The 
inverse phenotypes displayed by the hptB mutant and 
PA3346/PA3347-lacking strains strongly indicate that HptB 
antagonizes the activity of PA3346/PA3347.
 Microarray studies revealed significant overlap 
between the hptB and retS mutant transcriptomes 
(Bordi, 2010). Both retS and hptB mutants displayed 
downregulation of T3S genes and upregulation of the pel 
genes; however only the retS mutant displayed increased 
T6S gene expression (Bordi, 2010). HptB overproduction 
failed to restore expression of T3S and pel genes in the retS 
mutant, indicating that HptB does not partner with RetS. As 
previously mentioned, the HptB pathway specifically alters 
rsmY expression (Bordi, 2010), although the reason for 
differential sRNA control is unknown. The upstream regions 
of rsmY and rsmZ are disparate and could be recognized 
by distinct regulatory factors (Brencic, 2009b, a). Secondary 
mutations in gacS or gacA suppress the hptB phenotype 
and suggest that HptB functions upstream or at the same 
level as the GacS/A system (Bordi, 2010). Taken together 
recent work elucidating the molecular mechanisms by 
which the Gac/Rsm pathway reciprocally controls acute 
and chronic virulence factors have uncovered novel means 
utilized by P. aeruginosa to modulate gene expression and 
phenotypes in response to, as yet, unknown environmental 
cues.
c-di-GMP signaling
c-di-GMP is an important and ubiquitous secondary 
signaling molecule in many bacterial species. The 
intracellular concentration of c-di-GMP within a cell is 
mediated by the opposing actions of two types of enzymes: 
diguanylate cyclases (DGC) containing GGDEF-domains 
that synthesize c-di-GMP; while phosphodiesterases 
(PDE) containing EAL or HD-GYP domains that degrade 
c-di-GMP. Several proteins have been identified that 
contain both GGDEF and EAL-domains, and thus may 
be capable of both synthesizing and degrading c-di-GMP. 
Additionally, proteins in various bacterial species have 
been identified that contain degenerate GGDEF domains, 
suggesting that these domains are not catalytically active 
but rather function as allosteric sites (Christen, 2005) and/
or c-di-GMP receptors (Newell, 2009). In the P. aeruginosa 
genome, 39 genes contain either a GGDEF, an EAL, or 
both domains (Figure 1D) (Kulasakara, 2006). Levels of 
c-di-GMP influence a wide range of phenotypes in diverse 
bacterial species including cellular responses that effect 
pathogenesis, including synthesis of adhesins and EPS 
mediating biofilm formation, motility, secretion, cytotoxicity, 
synthesis of secondary metabolites, and environmental 
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stress adaptation. Modulation of c-di-GMP is associated 
with control of biofilm formation and other group behaviors 
(Liberati, 2006; Merritt, 2007).
 In many bacterial species sessile and motile behaviors 
are coordinately, but inversely, regulated by c-di-GMP 
(Tamayo, 2007; Jonas, 2009). Biofilm formation is a surface-
associated sessile behavior that requires production of an 
EPS matrix. Biofilm development requires a number of 
steps from initial surface attachment, EPS matrix formation, 
and elaboration of a mature biofilm structure (Ryder, 2007). 
Cyclic-di-GMP promotes biofilm formation, in part, by 
positively regulating production of the extracellular matrix 
at both the transcriptional and allosteric level (Simm, 
2004; Hickman, 2005). Bacterial surface appendages are 
also important for a number of the developmental stages 
in biofilm formation, including motility toward a surface, 
initial attachment, and microcolony formation. One class of 
appendages involved in P. aeruginosa biofilm formation are 
the Cup (chaperone usher pathway) fimbriae. Cup fimbriae 
are composed of a multimer of the major fimbrial subunit 
forming the rod structure, which may or may not contain 
an attached tip adhesin to facilitate specific binding (Sauer, 
2004). Multiple cup gene clusters are present in various 
strains of Pseudomonas, and in the PAO1 genome three 
(cupA, cupB, and cupC) have been identified (Vallet, 2001). 
A cupA gene cluster mutant is defective in attachment to 
solid surfaces (Vallet, 2004).
Wsp Chemosensory System
WspR was among the first P. aeruginosa proteins identified 
that influence c-di-GMP formation. WspR consists of a CheY-
like phospho-receiver domain and a GGDEF domain that has 
DGC activity in vivo and in vitro (D'Argenio, 2002; Hickman, 
2005; Güvener, 2007). WspR is a response regulator encoded 
by the wsp operon (wspABCDEFR), which comprises a 
multi-component chemosensory system with homology 
to the well-characterized chemotaxis (Che) pathway of 
E. coli (Ridgway, 1977; D'Argenio, 2002; Güvener, 2007). 
The Wsp system consists of a putative methyl-accepting 
chemotaxis protein (WspA), a hybrid CheA-like histidine 
kinase (WspE), two CheW-like adaptor proteins (WspB 
and WspD) predicted to link WspA and WspE, a CheR-like 
methyltransferase (WspC) and a CheB-like methylesterase 
(WspF), predicted to modulate the methylation status and 
activity of WspA. Upon detection of the appropriate signal, 
WspA is predicted to activate the associated WspE histidine 
kinase, resulting in phosphorylation of the WspR receiver 
domain and DGC activation. Consistent with this model, 
purified WspR shows increased DGC activity following 
in vitro phosphorylation by the phosphate donor acetyl 
phosphate (Hickman, 2005). While the specific signals 
detected by the Wsp system are currently unknown (see 
below), inactivation of wspF (a putative methylesterase and 
negative regulator of Wsp signaling) results in increased 
cell aggregation, a wrinkly colony phenotype, enhanced 
biofilm formation, and increased intracellular levels of c-di-
GMP. The phenotype of a wspF mutant is suppressed in 
a wspF, wspR double mutant, indicating that activation of 
WspR DGC activity accounts for the profound phenotypic 
changes. Transcriptome comparison between the wild type 
PAO1 strain and an isogenic wspF mutant identified 560 
genes affected by wspF, including the psl and pel operons, 
which displayed increased transcript levels in the mutant. 
These findings indicate that the wsp chemosensory system 
modulates intracellular c-di-GMP levels and regulates 
biofilm formation (Hickman, 2005). Complexes of WspR 
protein appear transiently in the cytoplasm of bacteria 
with an active Wsp system, suggesting that Wsp clusters 
form and dissolve, creating localized concentrations of 
c-di-GMP (Güvener, 2007). Binding of c-di-GMP to large 
protein complexes is known to affect their activity, and the 
protein complexes involved in the synthesis of Pel and 
Psl EPS are likely targets of WspR-generated c-di-GMP. 
Güvener and colleagues (2007) determined that the Wsp 
signal transduction pathway is stimulated in response to 
solid surface contact, which likely involves signal detection 
by a surface appendage (Güvener, 2007). Taken together 
these results demonstrate that WspR localizes in a 
phosphorylation-dependent manner, indicating that spatial 
and temporal activation of WspR impacts both its activity 
and localization.
Cup fimbriae
Independent screens in strains PAO1 and PA14 identified 
a three-component system involved in the regulation of cup 
fimbriae expression, termed rocA1 (regulator of cup), rocR, 
and rocS1 (sadARS in PA14) (Kuchma, 2005; Kulasakara, 
2005). RocA1, RocS1, and RocR have significant homology 
to the Bordetella pertussis BvgA/S/R system involved in 
regulation of virulence gene expression (Kulasakara, 2005). 
RocS1 is a sensor kinase containing a PAS domain that is 
predicted to localize to the cytoplasm adjacent to the two 
transmembrane segments. PAS domains were originially 
identified for their function in sensing intracellular oxygen 
and/or redox potential (Taylor, 1999). RocA1 is a classical 
response regulator containing the HTH motif typical of DNA 
binding proteins. RocR contains an N-terminal CheY-like 
phosphoryl receiver domain, suggesting that the aspartate 
residue present in this domain is phosphorylated by a 
sensor kinase (Kuchma, 2005). RocR also possesses a 
degenerate EAL domain suggesting that it may be involved 
in the hydrolysis of c-di-GMP. Further characterization 
of the rocARS transposon mutants confirmed that 
RocS1 and RocA1 activate transcription of the cupB and 
cupC gene clusters, while deletion of rocR resulted in a 
minimal increase in cupC-lacZ transcriptional reporter 
activity (Kulasakara, 2005). RocA1 is required for RocS1-
mediated activation of the cup gene clusters. In addition, 
the observation that RocS1 overexpression in the absence 
of rocA1 had no effect on cup gene expression supports a 
mechanism whereby RocA1 activates cup gene expression 
via RocS1 phosphorylation. RocR antagonizes the activity 
of RocA1, and two-hybrid analysis suggests this regulation 
is achieved through direct interaction of RocR with RocS1 
preventing RocA1 phosphorylation (Kulasakara, 2005). 
Because RocR contains a degenerate EAL domain, it 
was initially hypothesized that RocR does not possess 
catalytic activity; but instead the degenerate domain would 
serve as a binding site for c-di-GMP and binding would 
then influence RocR activation. However, recent work 
has demonstrated the degenerate EAL domain within 
RocR does possess catalytic activity and facilitates the 
hydrolysis of c-di-GMP to the dinucleotide 5’ pGpG (Rao, 
2008). Transcriptome analysis identified additional genes 
influenced by mutations in the RocA/R/S system, during 
either planktonic or biofilm growth. Wild type bacteria and 
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rocR/S mutants differentially regulated several genes during 
planktonic growth, but an even more significant difference in 
the number of differentially regulated genes was observed 
after 5 days of biofilm growth. Among the genes displaying 
the most significantly altered expression in these studies 
were genes encoding the T3SS, where several T3SS genes 
(apparatus components and effectors) were elevated in the 
rocR/S mutant biofilm in comparison to the wild type biofilm 
(Kuchma, 2005). The mechanism by which the RocA/R/S 
system influences the expression of additional genes is not 
clear.
 The RocA/R/S system regulates later steps in biofilm 
formation; rocARS mutants display initial defects in 
attachment but by 24 hours display surface attachment 
comparable to that of wild type (Kuchma, 2005). However, 
during biofilm growth in a flow-cell, rocARS mutants fail 
to form macrocolonies with defined borders and channel 
networks, an architecture displayed by the wild type strain 
by day 5. All three components of the RocA/R/S system 
appear to be required for mature biofilm formation, as each 
individual mutant confers the same defect in mature biofilm 
formation by day 5 during flow cell growth (Kuchma, 2005). 
As many genes required for formation of the T3SS were 
downregulated in rocARS mutants, the RocA/R/S system 
may control the switch from cytotoxicity, an acute virulence 
phenotype, to biofilm formation, a chronic virulence 
phenotype or an alterative lifestyle during growth in a hostile 
environment.
 P. aeruginosa strain PA14 is a more virulent clinical 
isolate than PAO1, although both share a similar host range 
(Rahme, 1995). The PA14 genome contains a pathogenicity 
island (PAPI-1) that is absent from the PAO1 genome, 
which carries many genes of unknown function and a fourth 
cup gene cluster (cupD)(He, 2004). Directly adjacent to 
the cupD gene cluster, are two divergently oriented sets of 
genes encoding TCS regulatory systems. The cupD gene 
cluster and these regulatory components are flanked by 
inverted repeats, suggesting they have been simultaneously 
acquired. One of these regulatory components, pvrR was 
previously shown to encode a “phenotype variant regulator” 
involved in regulating of the frequency of antibiotic resistant 
variants (Drenkard, 2002). PvrR contains an EAL domain, 
and therefore likely possesses PDE activity. The second 
TCS adjacent to the cupD gene cluster has been annotated 
rcsB (response regulator) and rcsC (sensor kinase) due 
to sequence homology with TCS systems present in 
Salmonella enterica and E. coli (Mikkelson, 2009). Previous 
studies have demonstrated the contribution of these genes 
to PA14 virulence in both animals and plants by analyzing 
transposon (Rahme, 1997) or in-frame deletion mutants 
(He, 2004). cupD gene expression, although not induced 
under laboratory conditions, is activated by RcsB and is 
repressed by the putative cognate sensor, RcsC (Mikkelson, 
2009; Nicastro, 2009). PvrR shows high similarity (45%) to 
the response regulator RocR, which down-regulates cupB 
and cupC expression (Drenkard, 2002; Kulasakara, 2005). 
Indeed, Mikkelson (2009) and colleagues demonstrated 
that pvrR expression antagonizes cupD gene cluster 
activation via RcsB. Both RocR and PvrR contain EAL 
domains within their output domains but lack the classical 
H-T-H motif, suggesting that they regulate Cup fimbriae 
expression by modulating c-di-GMP levels rather than by 
direct DNA binding (Kulasakara, 2005; Mikkelson, 2009). 
These findings support the theory that high levels of c-di-
GMP promote a biofilm-like lifestyle, while low levels of c-di-
GMP restrict bacteria to a planktonic mode of growth.
Biofilm Formation and Adherence
FimX is another protein involved in regulating motility in P. 
aeruginosa and is required for twitching motility (Huang, 
2003). In addition, Tfp are required for adherence and 
biofilm formation in P. aeruginosa. FimX contains both 
GGDEF and EAL domains involved in modulating c-di-GMP 
levels, although FimX does not appear to possess DGC 
activity (Kazmierczak, 2006). Through analysis of a series 
of deletion mutants Kazmierczak et al. (2006) demonstrated 
that both intact GGDEF and EAL domains are required 
for FimX PDE activity and restrict localization to a single 
bacterial pole. These results support the hypothesis that 
the GGDEF domain of FimX functions as an allosteric site 
for binding of GTP, which activates FimX PDE activity. 
Consistent with this hypothesis, mutation of the GGDEF 
domain in FimX, abolishes GTP binding and stimulation 
of PDE activity (Kazmierczak, 2006). However, recent 
structural studies indicate that the degenerate GGDEF 
domain of FimX is incapable of nucleotide binding, while 
the EAL domain binds c-di-GMP with high affinity inducing a 
conformational change that may impede FimX binding to its 
putative partner located at the bacterial pole to regulate Tfp 
production and twitching motility (Navarro, 2010; Qi, 2011).
 Starkey et al., identified genes transcriptionally 
upregulated in response to elevated c-di-GMP levels, 
revealing a small (35) subset of induced genes (Starkey, 
2009). Although most of the identified genes belonged 
to either the pel or psl gene clusters, one target belongs 
to a two-partner secretion (TPS) system encoding a 
secreted adhesin and its transporter. Borlee et al. (2010) 
renamed PA4625 and PA4624, cdrA (cyclic diguanylate-
regulated TPS partner A) and cdrB respectively, based 
on the observation that transcription of this TPS system 
is c-di-GMP-dependent. CdrA is processed at both the 
C- and N-termini, although following secretion full-length 
CdrA appears to be the major cell-associated species. 
Rugose small colony variants (RSCV) are characterized by 
formation of large cell aggregates and increased biomass, 
this phenotype can be caused by wspF mutation, which 
leads to WspR activation (D'Argenio, 2002; Hickman, 
2005). A dramatic phenotype was observed when a cdrA 
mutation was introduced into the wspF background, the 
resulting biofilm cells were less tightly packed than the cell 
clusters observed in a wspF mutant, suggesting that CdrA 
is involved in promoting auto-aggregation. As the cdrAB 
and psl/pel gene clusters are co-regulated, Borlee and 
colleagues hypothesized that CdrA may bind to either Psl 
or Pel EPS, this hypothesis is supported by the presence 
of an N-terminal carbohydrate-binding domain. Indeed, as 
predicted psl mutant strains did not auto-aggregate when 
cdrAB was overexpressed. Importantly, the production of 
CdrA was not affected by pslBCD mutation, nor were Psl 
levels significantly affected by cdrA mutation. Furthermore, 
CdrA was demonstrated to bind directly to Psl (Borlee, 
2010). The findings from this study highlight that biofilms 
are not simply random distributions of secreted polymers 
with imbedded bacterial cells, but are complex and more 
ordered than originally appreciated.
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Small-colony Variants
In chronic isolates from CF patients, small colony variants 
(SCV) are often observed and this phenotype has been 
correlated with poor lung function and enhanced antibiotic 
resistance (Häussler, 2004). SCVs are characterized by 
auto-aggregative properties, size, and enhanced biofilm 
formation. SCV phenotypes may also arise following 
exposure to antibiotics in vitro and from biofilm cultures 
(Drenkard, 2002).
 To investigate the factors involved in the SCV 
phenotype, Meissner and colleagues (2007) screened 
10,000 transposon mutants of the clinical SCV 20265 
isolate for reversion to the wild type phenotype. Two 
transposon insertions mapped to the cupA gene cluster 
involved in biofilm formation (Vallet, 2001), and two others 
mapped to PA1119 and PA1120, encoding hypothetical 
proteins (Meissner, 2007). To determine the involvement 
of CupA expression in the SCV phenotype, Meissner et al. 
compared CupA expression in SCV 20265 to the wild type 
strain and the cupA gene cluster transposon mutants via 
immunoblot. CupA expression was elevated in SCV20265 
relative to its clonal wild type while the cupA gene cluster 
transposon mutants displayed no CupA expression. CupA 
expression was also diminished in the other transposon 
mutants that displayed reversion to the wild type phenotype 
(Meissner, 2007).
 Reversion from the SCV 20265 auto-aggregative 
phenotype to a wild type phenotype also resulted from 
insertions in PA1120 and morA, both of which possess a 
transmembrane domain and a C-terminal GGDEF domain. 
Previously, PA1120 was demonstrated to possess DGC 
activity and to modulate biofilm formation (Kulasakara, 
2005). In addition to a GGDEF domain, the motility regulator 
MorA also contains an EAL domain. Expression of plasmid-
encoded PA1120 restored CupA expression in both the SCV 
20265 PA1120 and SCV 20265 morA mutants, suggesting 
that c-di-GMP levels are important for CupA fimbriae 
expression. Further analyses demonstrated that c-di-GMP 
levels were elevated (2.7-fold) in the SCV 20265 compared 
with wild type. Taken together these results demonstrate that 
alteration of global c-di-GMP levels is sufficient to induce 
CupA expression. Additionally, the GGDEF domain of MorA, 
but not the EAL domain, is important for its enzymatic 
activity as PA1120 overexpression could complement the 
SCV 20265 morA mutant for CupA expression (Meissner, 
2007).
 Ueda and Woods identified TpbA in a transposon 
mutant library screen for mutants with enhanced biofilm 
formation (Ueda, 2009b). A tpbA mutant displayed increased 
attachment to polystyrene and a defect in swarming motility, 
but no alteration in rhamnolipid production (Ueda, 2009a). 
Similar to a wspF mutant, the tpbA mutant displayed a 
wrinkly colony phenotype on Congo-red plates, implying 
increased production of EPS. Transcriptome analysis of a 
tpbA mutant revealed enhanced expression of the pelACDF 
genes and the biofilm matrix adhesin CdrA. The expression 
of tpbA was also upregulated, suggesting auto-regulation 
(Ueda, 2009a).
 In independent transposon mutagenesis screens, 
Ueda and Wood (2009) as well as Malone and colleagues 
(2010), identified components of the yfiBNR operon as 
important for biofilm formation and SCV morphology. Ueda 
and Woods initially identified TpbB (YfiN) due to its ability 
to suppress the hyperbiofilm phenotype of the tpbA mutant. 
Mutations in yfiR also suppressed the autoaggregative 
phenotype of the tpbA mutant (Ueda, 2009a). TpbA is a 
periplasmic protein with dual phosphatase activity, capable 
of dephosphorylating both tyrosine and serine/threonine 
residues (Pu, 2010). TpbB is an integral membrane protein 
containing a GGDEF domain, previously shown to possess 
DGC activity (Kulasakara, 2006). In follow-up studies, Pu 
and Wood demonstrated that TpbB is phosphorylated 
in a tpbA mutant, at both tyrosine and serine/threonine 
residues (Pu, 2010). Upon incubation of purified TpbA 
with phosphorylated TpbB, phosphorylation of TpbB is 
diminished, demonstrating that TpbB is a substrate of 
TpbA. Further, treatment of biofilm growth cultures with the 
phosphatase inhibitor trisodium orthovanadate increased 
biofilm formation, indicating that cellular phosphorylation 
enhances biofilm formation in P. aeruginosa (Ueda, 2009a).
 Three independent insertions were mapped to yfiR, the 
first gene of a predicted three-gene operon yfiBNR (Malone, 
2010). YfiR is a periplasmic protein, previously identified as 
a suppressor of the tpbA mutant phenotype (Ueda, 2009a). 
YfiB is a predicted outer-membrane lipoprotein containing 
a conserved OmpA peptidoglycan-binding domain. As 
a strong link between c-di-GMP and the SCV phenotype 
exists, Malone and colleagues hypothesized that the SCV 
phenotype of the yfiR mutant was the result of upregulation 
of TpbB activity due to release of YfiR-mediated repression. 
The cellular concentration of c-di-GMP measured in the yfiR 
mutant displayed a significant increase in c-di-GMP when 
compare to wild type; this observation coupled with the 
results demonstrating DGC activity of purified TpbB (lacking 
the transmembrane domain) support the hypothesis that 
YfiR represses the DGC activity of TpbB (Malone, 2010). 
Epistasis experiments were performed to determine the 
regulatory interplay of YfiB, YfiR, and TpbB. Deletion of yfiB 
did not affect attachment or colony morphology while the 
yfiRB double mutant displayed the phenotypes of a yfiR single 
mutant (SCV phenotypes), suggesting that YfiB functions 
upstream of YfiR. Additional experiments demonstrated that 
the stoichiometry of YfiR and TpbB are important for tight 
control of the system, as increased levels of TpbB relative 
to YfiR resulted in the SCV morphology (Malone, 2010). 
In vitro crosslinking experiments and bacterial two-hybrid 
analysis attempted to determine the link between YfiB and 
YfiR function. The crosslinking experiments suggested that 
oligomerization of YfiR depends upon the presence of YfiB, 
but not TpbB. The observed YfiR multimer was present at a 
size consistent with formation of a YfiR homodimer, yet the 
role of this complex was not defined. Additionally, bacterial 
two-hybrid analysis failed to demonstrate direct interaction 
between YfiR and TpbB, or between YfiB and either YfiR or 
TpbB.
 Taken together the results of the studies performed by 
Wood and colleagues and Malone et al., demonstrate that 
the activity of the DGC TpbB is tightly controlled. Strong 
evidence demonstrates that TpbB is phosphorylated on 
both tyrosine and serine/threonine residues, and this 
phosphorylation is important for TpbB activity. However, 
it remains unclear which kinase is responsible for TpbB 
phosphorylation. Furthermore while it is evident that YfiR 
and TpbA both control TpbB function through distinct 
mechanisms, it remains to be determined if these involve 
discrete signaling pathways. Further biochemical studies 
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are necessary in order to deduce the mechanism by which 
YfiB intergrates with YfiR and TpbB.
SadB/C/BifA pathway
Studies performed by George O’Toole’s group have identified 
several factors that are involved in inversely regulating 
surface-associated behaviors (Caiazza, 2004, 2007; 
Kuchma and O’Toole, 2007; Merritt, 2007). Previously, a 
genetic screen identified surface attachment-defective (sad) 
mutants of P. aeruginosa PA14, defined by their inability to 
form biofilms in a microtiter dish biofilm assay (O'Toole, 
1998, 2000). Subsequent characterization of mutants 
identified by this study revealed a genetic pathway involved 
in coordinately regulating surface-associated behaviors 
in P. aeruginosa PA14. The sadB mutant was originally 
identified as biofilm-defective in a genetic screen (O'Toole, 
1998, 2000). Further investigation demonstrated that the 
sadB mutant did not display a defect in flagellum-mediated 
swimming motility or Tfp-dependent twitching motility 
(Caiazza, 2004). However, the sadB mutant displayed a 
significant increase in swarming motility when compared to 
wild type. Caiazza et al. further demonstrated that the sadB 
mutant could initiate surface attachment but was unable 
to transition from reversible to irreversible attachment, an 
early step in biofilm formation (Caiazza, 2004). Levels of 
SadB were positively correlated with biofilm formation and 
irreversible attachment and fractionation studies localized 
SadB to the cytoplasm.
 In subsequent studies, an additional mutant sadC, 
identified in the original genetic screen (O'Toole, 1998), 
displayed surface-associated phenotypes mimicking the 
sadB mutant, including hyperswarming and a defect in biofilm 
formation. SadC is a DGC localized to the inner membrane 
that positively affects global c-di-GMP levels (Merritt, 2007). 
The sadC mutant was deficient in production of EPS, 
however pelA/pelG transcripts were unaffected by sadC 
mutation. Additional work identified yet another component 
of the pathway involved in regulating P. aeruginosa surface-
associated behaviors, the phosphodiesterase BifA. A 
bifA mutant displays opposing phenotypes to the sadB/C 
mutants, a bifA mutant is deficient in swarming motility 
and displays increased biofilm formation (Kuchma and 
O’Toole, 2007). Although, BifA contains both a GGDEF 
and an EAL domain, BifA does not appear to possess 
DGC activity. Instead, the GGDEF residues likely bind the 
allosteric activator GTP, as PDE activity was diminished 
in GGDEF residue mutants (Kuchma and O’Toole, 2007). 
Epistasis studies have aided in elucidating the hierarchy 
of the aforementioned proteins and indicate that BifA 
and SadC function in the same genetic pathway (Merritt, 
2007). Mutating sadC in the bifA background resulted in 
significant reduction of the hyperbiofilm phenotype and 
partial restoration of swarming motility. However, neither 
of these phenotypes were completely restored to wild type 
levels, suggesting that other DGCs likely contribute to 
overall c-di-GMP levels (Merritt, 2007). In a sadB mutant 
background, expression of sadC on a multicopy plasmid 
results in diminished biofilm formation in comparison 
to wild type, indicating that sadB is likely downstream 
of sadC in the pathway. These results support a model 
where environmental cues are sensed/received by SadC, 
resulting in altered c-di-GMP production. BifA can further 
regulate the signal through the activity of its EAL domain. 
Lastly, SadB is predicted to be involved in the transmission 
of the signal to Pel machinery and components of the 
chemotaxis machinery in order to regulate biofilm formation 
and swarming motility (Caiazza, 2004, 2007; Merritt, 2007). 
These findings suggest that the nearly 40 P. aeruginosa 
DGC/PDE enzymes generate specific phenotypic outputs 
by altering subcellular c-di-GMP pools. Indeed, recent work 
by Merritt et al. (2010) demonstrated that changes in total 
c-di-GMP levels did not account for the surface-associated 
behaviors displayed by DGC mutants (Merritt, 2010).
Cross-talk between signaling pathways
Our knowledge of the signaling pathways controlling P. 
aeruginosa is often based on dramatic phenotypic changes 
resulting from loss-of-function mutations that either fully 
activate or eliminate signaling under well-controlled 
laboratory conditions. However, in the environment or 
host, we hypothesize that a more gradual transition occurs 
between lifestyles. This concept is supported by the fact that 
the regulatory pathways discussed above are not insulated 
from one another; rather there exists substantial cross-
talk between the systems indicating a more sophisticated 
signaling network and the potential for a continuum of 
phenotypes (Figure 1). To emphasize this point, we will 
highlight several mechanisms of cross-talk that are relevant 
to this review.
 One of the best-described links between the lifestyle-
determining regulatory pathways is the role of the cAMP/Vfr 
signaling system in controlling the QS response. Specifically, 
Vfr has been shown to control the QS regulatory cascade 
by directly activating transcription of lasR and rhlR (Albus, 
1997; Croda-García, 2011). Furthermore, it has been shown 
that under planktonic growth conditions, Vfr protein levels 
increase substantially during the transition to stationary 
phase (Heurlier, 2003), a mechanism that may serve to fine-
tune the timing of QS gene expression. While these findings 
demonstrate a regulatory link between the cAMP/Vfr and 
QS signaling pathways, recent studies indicate that this 
regulatory connection is more complicated than originally 
appreciated. In contrast to other Vfr-regulated targets, the 
control of lasR expression is cAMP-independent (Fuchs, 
2010a). As stated previously, vfr expression is auto-
regulated in a cAMP-dependent manner (Fuchs, 2010a). 
The existence of cAMP-independent regulation by Vfr 
implies that either basal Vfr levels are sufficient to drive lasR 
expression in the absence of cAMP, or that there are cAMP-
independent mechanisms that can control vfr expression. 
Consistent with the later, it has been shown that activation 
of the alginate regulatory pathway results in reduced vfr 
expression without altering intracellular cAMP levels (Jones, 
2010).
 As mentioned above, the cAMP/Vfr pathway is linked to 
the regulatory pathway for conversion to mucoidy in chronic 
P. aeruginosa CF infection. During the chronic phase of CF 
lung infection, P. aeruginosa frequently converts to the mucoid 
colony phenotype due to overproduction of the capsular 
polysaccharide alginate (Govan, 1996). The overproduction 
of alginate appears to be representative of the chronic 
infection phenotype, as mucoid conversion promotes 
persistence in the lungs and enhances resistance to immune 
defenses (Deretic, 1995; Pier, 2001). Mucoid conversion 
results, most frequently, from loss-of-function mutations in 
mucA, which encodes an anti-sigma factor (Boucher, 1997). 
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Inactivation of MucA releases the alternative sigma factor 
AlgU (AlgT) allowing AlgU to activate the transcription of 
numerous genes, including the gene encoding the AlgR 
response regulator (Figure 1E) (Wozniak, 1994; Govan, 
1996). Both AlgU and AlgR are necessary for activation 
of the genes encoding the biosynthetic enzymes required 
for alginate production, resulting in the mucoid phenotype 
(Mohr, 1992; Martin, 1994). Loss-of-function mutations 
in mucA are also associated with reduced expression of 
many acute virulence factors, including: the T3SS, ETA, 
LasA protease, and Tfp (Figure 1E) (Mohr, 1990; Wu, 2004; 
Jones, 2010). Recent work by our group demonstrated that 
mucA mutation blocks the production of invasive virulence 
factors by inhibiting the cAMP/Vfr signaling pathway at 
the level of vfr expression (Jones, 2010). This inhibition is 
mediated by AlgU and AlgR, but is independent of alginate 
production and cAMP synthesis. Inhibition of vfr expression 
via mucA mutation represents a mechanism for inverse 
regulation of acute and chronic virulence factors during 
infection, supporting the hypothesis that acute virulence 
factors are actively repressed during chronic P. aeruginosa 
infection in the CF lung. The mechanism of vfr repression 
by AlgR has yet to be elucidated (Jones, 2010). In addition 
to indirectly influencing QS through reduced vfr expression, 
AlgR has been shown to negatively regulate expression 
of rhlI and rhlR directly (Morici, 2007). EMSA studies have 
demonstrated that AlgR binds specifically to the rhlR-rhlI 
promoter, further strengthening the link between chronic 
human infection and the repression of QS.
 The c-di-GMP signaling pathway, via regulation of Alg44, 
also influences alginate production. It is now documented 
that increasing c-di-GMP levels by overexpression of 
DGCs enhances alginate production, and conversely 
PDE overexpression reduces alginate formation (Merighi, 
2007). Alg44, a protein required for alginate biosynthesis, 
contains a PilZ domain, previously shown to interact with 
c-di-GMP (Amikam, 2006). Merighi and colleagues (2007) 
characterized the PilZ domain of Alg44 and demonstrated 
that mutation of residues within the PilZ domain diminished 
binding of c-di-GMP and alginate production. Localization 
studies determined that Alg44 associates with the membrane 
and protein localization is not affected by mutations in 
the PilZ domain. These results are consistent with Alg44 
functioning as a regulator of the alginate polymerase (Alg8), 
a transmembrane protein (Merighi, 2007). The precise 
role of c-di-GMP binding on Alg44 function has yet to be 
elucidated.
 Although early reports correlated elevated c-di-
GMP levels with increased expression of polysaccharide 
synthesis genes, the mechanism facilitating this effect 
was unknown. FleQ was previously shown to repress 
expression of the pel operon (Dasgupta, 2002). Despite 
the absence of characterized c-di-GMP binding domains, 
FleQ bound radiolabeled c-di-GMP in vitro, and c-di-GMP 
binding inhibited FleQ-binding to the pel promoter transcript 
(Hickman, 2008). Because FleQ also activates genes 
involved in flagellar (acute virulence factor) biosynthesis, 
this regulation represents another mechanism for inverse 
control of acute (flagella) and chronic (Pel) virulence factors. 
Initial observations of Vfr-mediated repression of fleQ 
expression were perplexing, as Vfr is known to positively 
regulate virulence factors involved in acute infection. 
However, FleQ repression of chronic phenotype-associated 
factors suggests that Vfr is also involved in downregulating 
acute virulence factors (flagella) and unexpectedly indirectly 
mediates expression of chronic virulence factors (Pel 
polysaccharide) through repression of fleQ.
 Both mutations in retS, or high intracellular c-di-GMP 
levels, can induce induce biofilm formation suggesting 
that the Gac/Rsm pathway and c-di-GMP may intersect to 
control the expression of chronic virulence factors. Recently, 
work by Moscoso and colleagues has further established 
the link between the Gac/Rsm pathway and c-di-GMP 
by demonstrating that retS mutants themselves display 
high levels of c-di-GMP (Moscoso, 2011). RetS inversely 
controls the expression of the genes encoding the T3SS 
and the T6SS, which are associated with chronic infections 
(Goodman, 2004; Mougous, 2006; Brencic, 2009a). WspR 
DGC activity is finely controlled, however, mutation of 
a single residue within the I-site (WspRR242A) results in a 
constitutively active enzyme. Overexpression of WspRR242A 
enhanced biofilm formation and elevated EPS production. 
Additionally, the influence of c-di-GMP levels on the T3SS/
T6SS switch was investigated by expressing WspRR242A 
in a pelA background. The roughly twofold increase in 
c-di-GMP levels observed in this strain coincided with a 
reduction in PcrV (T3SS) production and an increase in 
Hcp-1 (T6SS) production. Overexpresion of another DGC, 
TpbB (YfiN) similarly resulted in a switch between the 
expression of the T3SS and the T6SS. Therefore, artificial 
increases in c-di-GMP, via DGC overexpression, inversely 
controls expression of the T3SS and the T6SS. Consistent 
with this result, overexpression of the PDE PA2133 in a retS 
mutant reverted the T3SS and T6SS expression profiles. 
In the absence of RsmY and RsmZ, DGC overexpression 
is no longer able to induce a switch from T3SS to T6SS 
expression indicating that RsmY and RsmZ are required for 
the c-di-GMP-dependent switch between T3SS and T6SS 
(Moscoso, 2011). These findings establish a direct link 
between the Gac/Rsm and c-di-GMP dependent pathways.
 One final cross-talk mechanism is Gac/Rsm pathway 
control of cAMP/Vfr signaling through modulation of vfr 
expression. Microarray analysis revealed a twofold decrease 
in vfr expression in a rsmA mutant compared to PAO1 wild 
type. Additionally, analysis of vfr transcriptional fusions 
demonstrated decreased vfr expression in the rsmA mutant 
compared to PAO1 (Burrowes, 2006). Consistent with these 
findings, many of the acute virulence factors activated by 
RetS depend upon Vfr for expression (Goodman, 2004). 
In general, a consistent theme has emerged, whereby the 
Gac/Rsm pathway appears to promote expression of acute 
virulence factors though a Vfr-dependent mechanism, but 
represses chronic phenotypes through a Vfr-independent 
mechanism.
 Cross-talk amongst the regulatory signaling pathways 
described here most often occurs at the transcriptional level 
(i.e. Vfr control of QS and AlgR control of QS), where different 
pathways regulate overlapping sets of genes. However, 
cross-talk can also occur via post-transcriptional regulation 
(i.e. c-di-GMP binding: Alg44 and FleQ). Collectively, the 
studies reviewed here suggest that P. aeruginosa signaling 
pathways are arranged in complex circuits with extensive 
cross-talk at multiple levels, thereby providing cells the 
ability to generate a finely tuned and progressive response 
to a range of stimuli.
 The aforementioned pathways play a critical role in 
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determining P. aeruginosa lifestyle by detecting various 
environmental conditions and controling global phenotypic 
changes. In many cases, the environmental cues that 
influence these signaling pathways remain unknown. 
However, in some instances potential signals have 
been elucidated. For example, the cAMP/Vfr signaling 
pathway is responsive to low calcium levels and osmotic 
stress (Wolfgang, 2003 and Rietsch, 2006). It has been 
hypothesized that the Gac/Rsm pathway may respond 
to carbohydrate signals, as the hybrid sensors RetS and 
LadS contain carbohydrate-binding domains (Goodman, 
2004 and Ventre, 2006). Recent work by O’Callaghan and 
colleagues (2011) demonstrated that oxygen availability, 
detected through the anaerobic response regulator 
Anr, modulates rsmY/Z expression and thus Gac/Rsm-
dependent phenotypes. QS is controlled by both the cAMP/
Vfr and Gac/Rsm pathways and thus signals that trigger 
these pathways, ultimately influence QS gene expression. 
In addition, membrane perturbations and the stringent 
response have previously been shown to influence QS 
(van Delden, 2001; Baysse, 2005), indicating that nutrient 
starvation/availability plays a substantial role in determining 
P. aeruginosa social behavior. The signals influencing 
c-di-GMP levels remain largely unknown, although recent 
work demonstrates that the availability of specific amino 
acids influence c-di-GMP levels and surface-associated 
behaviors (Bernier, 2011). Furthermore, surface contact or 
attachment itself appears to represent an important cue for 
c-di-GMP production (Güvener, 2007). Given the plethora of 
enzymes involved in c-di-GMP synthesis and degradation, 
it is plausible that many additional environmental cues 
contribute to regulation of c-di-GMP levels. The physiological 
relevance of these signals, in the context of a complex 
environmental or host niche, has yet to be determined and 
represents an important and daunting future direction for 
the field. Current progress in this area is severely hampered 
by the lack of tractable model systems and the fact that 
many of the signals mentioned are likely to have pleiotropic 
effects.
Concluding Remarks
While it is convenient to think of P. aeruginosa infection 
as a switch between acute and chronic phenotypes it has 
become clear that infection, like environmental lifestyle, 
is a finely-balanced continuum and involves substantial 
overlap and cross-talk between environmental detection 
systems. We envision a model (Figure 2) whereby the 
transition from acute to chronic virulence phenotype during 
infection closely parallels the gradual changes observed 
during the shift from a planktonic to sessile lifestyle within 
an environmental reservoir. Further, a similar transition 
from a sessile to planktonic lifestyle can occur within the 
environment enabling dissemination to new environmental 
niches. We hypothesize that this sessile to planktonic 
switch also occurs durig chronic human disease, although 
the mechanism and implications are less clear.
 In the planktonic environmental lifestyle of P. 
aeruginosa, individual or small groups of free-living bacteria 
have the capacity to evade or defend against bacterivorous 
protozoan and metazoan predators (Hilbi, 2007). To do 
so, P. aeruginosa relies on cAMP/Vfr signaling to facilitate 
expression of many traditional “virulence factors” like the 
T3SS, which in an environmental reservoir is an important 
defense mechanism against phagocytosis by predators. 
Additionally, in this planktonic phase P. aeruginosa expresses 
appendages which mediate motility, providing yet another 
mechanism for avoiding predation and facilitating dispersal. 
The cAMP/Vfr signaling cascade controls the QS pathway. 
Once a quorum is reached, the bacteria begin to exhibit 
population behaviors, such as the secretion of degradative 
enzymes and toxins, which in significant concentrations can 
liberate nutrients from environmental sources and provide 
defense against predators and competing bacterial species. 
Similarly, in acute human infection the virulence phenotype 
of P. aeruginosa is dominated by the expression of virulence 
factors that are cytotoxic and invasive (T3SS, T2SS, flagella, 
Tfp) which cause tissue damage, sepsis and contribute to 
bacterial dissemination. The cAMP/Vfr and QS pathways 
largely control expression of these virulence factors.
 In times of limited nutrients or substantial predation, 
P. aeruginosa can adapt a sessile biofilm lifestyle as a 
defense mechanism for evading predators and restricting 
metabolic demands. Upon attachment to a surface, the 
pathways leading to a sessile lifestyle (c-di-GMP, Gac/
Rsm) become activated. Attachment is initially dependent 
upon the expression of cAMP/Vfr-regulated genes, such 
as those necessary for Tfp expression and QS. As the 
bacteria population transitions to the sessile lifestyle these 
pathways are ultimately repressed and those involved 
in EPS production and biofilm formation are activated. 
During persistent or chronic human infection, P. aeruginosa 
frequently transitions to a noncytotoxic and minimally 
invasive virulence phenotype, adopting a biofilm lifestyle, 
which protects against host immune system insults and 
provides resistance to antibacterial therapy.
 The last aspect of this model is that at any given time 
individuals residing in the environmental sessile community 
can transition from this lifestyle to once again become 
motile to seek new nutrient sources and more favorable 
environmental conditions. Similarly, we envision that 
individual members of a biofilm community, within the context 
of infection, can leave the biofilm and reemerge as individual 
motile bacteria. This transition may facilitate spread to a 
new colonization site within the CF lung and the renewed 
expression of acute virulence factors may contribute to the 
frequent bouts of exacerbation experienced by CF patients 
with chronic P. aeruginosa infection. Additionally, in the case 
of chronic biofilm infection of catheters, this reemergence 
of motile and cytotoxic bacteria may explain the periodic 
development of septicemia. Analogous to the environmental 
lifestyle transition, we hypothesize that the conversion to a 
chronic virulence phenotype occurs via a continuum, where 
the bacterial population largely transitions from cAMP/Vfr 
and QS-dominated phenotypes to c-di-GMP and Gac/Rsm-
dominated phenotypes.
 While this review primarily focuses in the regulatory 
pathways used by P. aeruginosa to generate a phenotypic 
continuum in response to extracellular signals, it is 
important to note that genetic variability also contributes 
to dynamic phenotypes within P. aeruginosa populations. 
This is best exemplified in chronic P. aeruginosa infections. 
Current evidence supports the idea that P. aeruginosa 
infection in CF largely involves a clonal population; 
however, there is abundant evidence that this population 
undergoes diversification through the accumulation of 
mutations (Bragonzi, 2009). Early evidence suggested that 
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these mutations are in fact selected for (Nguyen, 2006; 
Smith, 2006). The majority of documented loss-of-function 
mutations accumulate in the alginate regulatory pathway 
(mucA), QS system (lasR) and cAMP signaling system (vfr 
and cyaB) as well as the downstream targets controlled 
by these systems (Smith, 2006; D'Argenio, 2007; Wilder, 
2009; Yang, 2011). In general, these mutations reduce the 
capacity of individual isolates to cause acute and invasive 
infection (Bragonzi, 2009), supporting the notion that acute 
and persistent infections involve distinct and potentially 
mutually exclusive phenotypic strategies. However, the 
maintenance of wild type alleles within the overall P. 
aeruginosa population suggests the need to maintain a full 
phenotypic repertoire. In particular, the spread of chronic 
infection (e.g. during exacerbation) to otherwise naive sites 
within the CF lung may require the capacity to initiate an 
acute virulence phenotype.
 In opportunistic pathogens, regulatory systems must 
promote changes in gene expression to facilitate transition 
from an environmental reservoir to the host. Temporal 
control and spatial localization may allow ubiquitous signals 
to elicit specific responses. The ability of P. aeruginosa to 
occupy diverse environmental habitats and cause a wide 
variety of infections depends on a complex series of global 
regulatory networks that integrate diverse extracellular 
signals to coordinate phenotypic change. Intense study 
over the past decade has generated a wealth of information 
about the complex lifestyle of P. aeruginosa; however, many 
questions remain to be answered.
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